{'fraction_non_alphanumeric': 0.018329938900203666, 'fraction_numerical': 0.010183299389002037, 'mean_word_length': 5.739726027397261, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
This week in Neurology®

See p. 1365 Antibodies in patients with neuropsychiatric systemic lupus erythematosus The authors identified 6 antibodies in the sera from patients with neuropsychiatric systemic lupus erythematosus (NPSLE) using proteomic analysis. One of these antibodies was against GDI (Rab guanosine diphosphate dissociation inhibitor ) in those with psychosis. The antiGDI antibody is a candidate for further exploration as diagnostic marker of psychosis associated with NPSLE.